Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 50
Filtrar
1.
Nat Biotechnol ; 17(1): 37-41, 1999 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-9920266

RESUMEN

Systemically administered tumor-targeted Salmonella has been developed as an anticancer agent, although its use could be limited by the potential induction of tumor necrosis factor alpha (TNFalpha)-mediated septic shock stimulated by lipid A. Genetic modifications of tumor-targeting Salmonella that alter lipid A and increase safety must, however, retain the useful properties of this bacteria. We report here that disruption of the Salmonella msbB gene reduces TNFalpha induction and increases the LD50 of this pathogenic bacteria by 10,000-fold. Notwithstanding this enormous difference, Salmonella retains its tumor-targeting properties, exhibiting tumor accumulation ratios in excess of 1000:1 compared with normal tissues. Administration of this bacteria to mice bearing melanoma results in tumors that are less than 6% the size of tumors in untreated controls at day 18. Thus, the antitumor activity previously demonstrated using tumor-targeting Salmonella with normal lipid A is retained. Lipid modification of tumor-specific bacterial vectors provides a means for reducing septic shock and further suggests that the antitumor activity of these bacteria may be independent of TNFalpha.


Asunto(s)
Aciltransferasas , Proteínas de Escherichia coli , Lípido A/genética , Melanoma Experimental/terapia , Salmonella/fisiología , Salmonella/patogenicidad , Neoplasias Cutáneas/terapia , Factor de Necrosis Tumoral alfa/metabolismo , Animales , Proteínas Bacterianas/genética , Supervivencia Celular , Humanos , Lípido A/análogos & derivados , Hígado/microbiología , Macrófagos/microbiología , Ratones , Ratones Endogámicos , Trasplante de Neoplasias , Respiración , Salmonella/genética , Salmonelosis Animal/etiología , Salmonelosis Animal/prevención & control , Eliminación de Secuencia , Choque Séptico/microbiología , Choque Séptico/prevención & control , Porcinos , Virulencia/genética
2.
Cancer Res ; 46(2): 493-7, 1986 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-3079662

RESUMEN

A new class of compounds, termed "dopa phosphates," is described. The compounds contain phosphate ester linkages at positions 3 and/or 4 of the phenylalanine ring. Dopa phosphates are highly soluble compounds which are stable over a wide range of pH values and are not hydrolyzed by boiling in concentrated acid. Synthetic yields of greater than 90% can be obtained using dopa as starting material. Exposure to alkaline phosphatase results in hydrolysis of the phosphate moieties and production of dopa. Dopa phosphates do not inhibit dopa oxidase (tyrosinase, EC 1.14.18.1) activity. Dopa oxidase does not catalyze the conversion of dopa phosphates into melanin unless the dopa phosphates are first treated with alkaline phosphatase. Dopa phosphates, when compared to L-dopa, are stable in the presence of O2 and are not oxidized by serum proteins. In the presence of cultured melanoma cells, dopa phosphates are readily converted into melanin, indicating that the cells are able to produce dopa from dopa phosphates. At high concentrations, dopa phosphates are cytotoxic toward melanoma cells in culture. The cytotoxicity is enhanced at least 3-fold by pretreatment of cells with melanotropin and is prevented by phenylthiourea, an inhibitor of dopa oxidase activity. These results, combined with studies on the uptake of radioactive forms of dopa phosphates (32P and 14C), indicate that phosphorylated isomers of dopa are efficiently taken up by Cloudman melanoma cells and are readily converted by the cells into a melanin precursor, presumably L-dopa.


Asunto(s)
Levodopa/análogos & derivados , Melaninas/biosíntesis , Melanoma/metabolismo , Animales , Transporte Biológico , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Levodopa/síntesis química , Levodopa/metabolismo , Levodopa/uso terapéutico , Melanoma/tratamiento farmacológico , Ratones , Monofenol Monooxigenasa/metabolismo , Fosforilación , Solubilidad
3.
Cancer Res ; 57(20): 4537-44, 1997 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-9377566

RESUMEN

There has been little investigation of bacteria as gene delivery vectors. Here, we demonstrate that genetically engineered Salmonella have many of the desirable properties of a delivery vector, including targeting of multiple tumors from a distant inoculation site, selective replication within tumors, tumor retardation, and the ability to express effector genes, such as the herpes simplex virus thymidine kinase (HSV TK). When wild-type Salmonella were introduced into melanoma-bearing mice, the bacteria were found within the tumor at levels exceeding 10(9) per g, although as pathogens, they caused the death of the mice. However, when attenuated, hyperinvasive auxotrophic mutants were used, the tumor-targeting and amplification phenomena were retained, whereas their pathogenicity was limited. With such attenuated strains, the tumor:liver ratios ranged between 250:1 and 9000:1. When these auxotrophs were inoculated i.p. into C57B6 mice bearing B16F10 melanomas, they suppressed tumor growth and prolonged average survival to as much as twice that of untreated mice. A plasmid containing the HSV TK gene with a beta-lactamase secretion signal was constructed that, when expressed, resulted in translocation to the periplasm and phosphorylation of the prodrug ganciclovir. Melanoma-bearing animals inoculated with HSV TK-expressing Salmonella showed ganciclovir-mediated, dose-dependent suppression of tumor growth and prolonged survival in addition to that seen with bacteria alone. The results demonstrate that attenuated Salmonella would be useful both for inherent antitumor activity and delivery of therapeutic proteins to cancer cells in vivo.


Asunto(s)
Neoplasias de la Mama/terapia , Neoplasias del Colon/terapia , Vectores Genéticos , Melanoma Experimental/terapia , Salmonella typhimurium/genética , Simplexvirus/genética , Timidina Quinasa/biosíntesis , Animales , Neoplasias de la Mama/microbiología , Neoplasias de la Mama/patología , Neoplasias del Colon/microbiología , Neoplasias del Colon/patología , Femenino , Ingeniería Genética , Humanos , Melanoma Experimental/microbiología , Melanoma Experimental/patología , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos DBA , Ratones Desnudos , Reacción en Cadena de la Polimerasa , Proteínas Recombinantes de Fusión/biosíntesis , Salmonella typhimurium/clasificación , Salmonella typhimurium/ultraestructura , Tasa de Supervivencia , Timidina Quinasa/genética , Células Tumorales Cultivadas , beta-Lactamasas/biosíntesis
4.
Cancer Res ; 60(9): 2512-9, 2000 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-10811133

RESUMEN

Cells from a lung metastasis, arising from Cloudman S91 melanoma cells implanted s.c. in the tail of a BALB/c nu/nu mouse, were comprised chiefly of host x tumor hybrids. These lung metastasis cells showed: (a) 30-40% increased DNA content; (b) resistance to 10(-4) M hypoxanthine, 4 x 10(-7) M aminopterin, and 1.6 x 10(-5) M thymidine (HAT) + G418; and (c) the presence in genomic DNA of genes for both wt and albino tyrosinase, reflecting the DBA/2J (Cloudman S91) and BALB/c mouse genotypes, respectively. Individual clones of lung metastasis cells expressed enhanced pigmentation, motility, and responsiveness to MSH/IBMX, a behavior similar to that recently reported for artificially generated melanoma x macrophage fusion hybrids. These similarities suggested that the host fusion partner generating the lung metastasis hybrids might have been a macrophage, although formal proof for this was not possible. The results provide the first direct evidence that host x tumor hybridization could serve as an initiating mechanism for melanoma metastasis.


Asunto(s)
Neoplasias Pulmonares/secundario , Melanoma/patología , Aminopterina/farmacología , Animales , Antibacterianos/farmacología , Antígenos CD/metabolismo , Protocolos de Quimioterapia Combinada Antineoplásica/farmacología , Movimiento Celular , Quimiotaxis , Citometría de Flujo , Gentamicinas/farmacología , Hipoxantina/farmacología , Immunoblotting , Neoplasias Pulmonares/ultraestructura , Proteínas de Membrana de los Lisosomas , Glicoproteínas de Membrana/metabolismo , Ratones , Ratones Endogámicos BALB C , Microscopía Electrónica , Monofenol Monooxigenasa/metabolismo , Trasplante de Neoplasias , Polimorfismo de Longitud del Fragmento de Restricción , Análisis de Secuencia de ADN , Timidina/farmacología , Factores de Tiempo , Células Tumorales Cultivadas
5.
Biochim Biophys Acta ; 1313(2): 130-8, 1996 Aug 28.
Artículo en Inglés | MEDLINE | ID: mdl-8781560

RESUMEN

It is demonstrated that ultraviolet B (UVB) radiation stimulates increased expression of the proopiomelanocortin (POMC) gene which is accompanied by production and release of alpha-melanocyte stimulating hormone (alpha-MSH) and adrenocorticotropin (ACTH) by both normal and malignant human melanocytes and keratinocytes. The production and release of both peptides are also stimulated by dibutyryl cyclic adenosine monophosphate (dbcAMP) and interleukin 1 alpha (IL-1 alpha) but not by endothelin-1 (ET-1) or tumor necrosis factor-alpha (TNF-alpha). N-acetyl-cysteine (NAC), a precursor of glutathione (GSH), an intracellular free radical scavenger, abolishes the UVB-stimulated POMC peptide production and secretion. Conclusions are as follows: (1) Cultured human cells of cutaneous origin, namely keratinocytes and melanocytes, can produce and express POMC; (2) POMC expression is enhanced by exposure to UVB, possibly through a cyclic AMP-dependent pathway; and (3) The action of UVB on POMC production may involve a cellular response to oxidative stress.


Asunto(s)
AMP Cíclico/fisiología , Queratinocitos/fisiología , Melanocitos/fisiología , Proopiomelanocortina/metabolismo , Rayos Ultravioleta , Acetilcisteína/farmacología , Hormona Adrenocorticotrópica/metabolismo , Secuencia de Bases , Bucladesina/farmacología , Células Cultivadas , Citocinas/farmacología , Cartilla de ADN/química , Endotelinas/farmacología , Expresión Génica/efectos de los fármacos , Expresión Génica/efectos de la radiación , Humanos , Hormonas Estimuladoras de los Melanocitos/metabolismo , Datos de Secuencia Molecular , ARN Mensajero/genética , Acetato de Tetradecanoilforbol/farmacología , Células Tumorales Cultivadas
6.
J Invest Dermatol ; 66(4): 201-9, 1976 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-178804

RESUMEN

Growth and melanization are intimately related in melanoma cells. MSH, by promoting elevated cyclic AMP levels, causes increases in melanization, cessation of growth, and gross morphologic changes in Cloudman S-91 melanoma cells. Growth inhibition results from high levels of cyclic AMP while growth stimulation occurs with lower levels. During melanization, oxidation products of tyrosine are generated which are toxic to the cells. Genetic studies have revealed that some of these processes are related through common biochemical pathways. This article reviews work of recent years on such regulatory mechanisms in melanoma.


Asunto(s)
Melaninas/biosíntesis , Melanoma/metabolismo , Animales , Neoplasias Óseas/metabolismo , Bromodesoxiuridina/farmacología , Catecol Oxidasa/metabolismo , División Celular/efectos de los fármacos , Línea Celular , Transformación Celular Neoplásica/efectos de los fármacos , Cricetinae , AMP Cíclico/metabolismo , Dihidroxifenilalanina/metabolismo , Hormonas Estimuladoras de los Melanocitos/farmacología , Hormonas Estimuladoras de los Melanocitos/fisiología , Melanocitos/metabolismo , Melanoma/etiología , Ratones , Neoplasias Experimentales/metabolismo , Virus Oncogénicos/aislamiento & purificación , Pigmentación , Tirosina/metabolismo
7.
J Invest Dermatol ; 79(1): 16-8, 1982 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-6806397

RESUMEN

Three new regulatory factors in the melanogenesis pathway were recently described: dopachrome conversion factor accelerates the conversion of dopachrome to 5,6-dihydroxyindole; indole conversion factor accelerates the conversion of 5, 6-dihydroxyindole into melanin; and indole blocking factor retards the conversion of 5, 6-dihydroxyindole into melanin. Exposure of wild-type Cloudman melanoma cells in culture to melanotropin (MSH) removes blocking factor activity and increases indole conversion factor activity. The chemical nature of factors has not yet been determined. In this report we demonstrate that highly purified isozymes of tyrosinase from C57B1/6N murine hair bulbs and B16 murine melanoma are closely associated with conversion and blocking factor activities. The soluble isozymes. T1, T2, and T2 contain blocking factor activity, while isozyme T4, the major tyrosinase species found in melanosomes, contains activity that accelerates melanin formation from dopachrome. The results suggest that melanogenesis is regulated by the association of these different factors with the specific tyrosinase isozymes.


Asunto(s)
Catecol Oxidasa/metabolismo , Cabello/metabolismo , Isoenzimas/metabolismo , Melaninas/biosíntesis , Monofenol Monooxigenasa/metabolismo , Animales , Melanocitos/enzimología , Melanoma/metabolismo , Ratones , Ratones Endogámicos C57BL , Piel/metabolismo , Neoplasias Cutáneas/metabolismo
8.
J Invest Dermatol ; 94(4): 461-4, 1990 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-2107263

RESUMEN

Melanocyte-stimulating hormone (MSH) induces melanogenesis in Cloudman mouse melanoma cells. The activities of two enzymes in the melanogenesis pathway, tyrosinase and dopachrome conversion factor, are increased as part of the induction process. Trans retinoic acid (RA), at concentrations as low as 0.1 nM, inhibited the induction of tyrosinase, dopachrome conversion factor, and melanogenesis, but had no effect on the basal levels of either enzyme or of cellular melanin content. Half-maximal effects of RA occurred at a concentration of 10 nM; maximal effects were observed at 1 microM. The effects of RA on melanogenesis were independent of its effects on cellular growth since one Cloudman line tested was growth-inhibited by RA and another was growth-stimulated by RA, but the induction of melanogenesis by MSH in both lines was inhibited by RA. Mixing experiments with cell lysates failed to demonstrate the induction of a tyrosinase inhibitor by RA. The effects of RA were not limited to MSH or to Cloudman melanoma cells since RA blocked cholera toxin-inducible melanogenesis in Cloudman cells, as well as the induction of tyrosinase activity by L-tyrosine in Bomirski hamster melanoma cells. The effects of RA were specific to melanogenesis, however, since RA did not interfere with MSH-induced changes in cellular morphology and growth. Thus, RA appears to be a new and potent tool for understanding mechanisms regulating induction of the pigmentary system.


Asunto(s)
Melanoma Experimental/patología , Pigmentación/efectos de los fármacos , Tretinoina/farmacología , Animales , Cricetinae , Isomerasas/antagonistas & inhibidores , Melaninas/biosíntesis , Ratones , Monofenol Monooxigenasa/antagonistas & inhibidores , Factores de Tiempo , Células Tumorales Cultivadas
9.
J Invest Dermatol ; 112(6): 853-60, 1999 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-10383729

RESUMEN

Immunohistochemical staining of human skin specimen showed the stronger localization of proopiomelanocortin peptides near the suprabasal layer of the epidermis, where keratinocytes are mostly differentiated. To test the possibilities of whether the production of proopiomelanocortin peptides or their receptor-binding activity or both is increased during differentiation of keratinocytes, we treated the cells in culture with Ca2+ to induce their differentiation. The production of proopiomelanocortin peptides and its gene expression were not induced significantly, but the binding ability of melanocortin receptor, as well as its gene expression were stimulated by Ca2+. Ultraviolet B irradiation, an inducer of differentiation, stimulated both proopiomelanocortin production and melanocortin receptor expression. These data show that normal human keratinocytes express melanocortin receptor similar to melanocytes, and that it is induced during differentiation.


Asunto(s)
Queratinocitos/citología , Queratinocitos/metabolismo , Receptores de Corticotropina/biosíntesis , Hormona Adrenocorticotrópica/metabolismo , Calcio/farmacología , Diferenciación Celular/efectos de los fármacos , Diferenciación Celular/fisiología , Diferenciación Celular/efectos de la radiación , Epidermis/metabolismo , Humanos , Queratinocitos/efectos de la radiación , Hormonas Estimuladoras de los Melanocitos/metabolismo , Proopiomelanocortina/biosíntesis , Proopiomelanocortina/genética , ARN Mensajero/metabolismo , Receptores de Melanocortina , Receptores de la Hormona Hipofisaria/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Piel/química , Rayos Ultravioleta
10.
J Invest Dermatol ; 103(2): 196-201, 1994 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-8040609

RESUMEN

Tyrosinase, tyrosinase-related protein-1 (TRP-1), and tyrosinase-related protein-2, (TRP-2, dopachrome tautomerase) were shown by immunoblotting and enzyme assays to copurify from extracts of Cloudman S91 melanoma cells. Antibodies to TRP-1 and TRP-2 immunoprecipitated tyrosinase activity, suggesting a stable interaction (complex) among these proteins. The tyrosine hydroxylase activity of tyrosinase was reduced in the complexed form; treatment with Triton X-100 dissociated the complex and activated the tyrosinase present within it. To further study this complex, we employed sucrose gradient density centrifugation of extracts from cultured murine melanocytes. Tyrosinase, TRP-1, and TRP-2 all existed in high molecular weight "multimers" of approximately 200 to > 700 kilodaltons. Extraction of cells with buffers containing the detergent CHAPS preserved the high molecular weight multimers; Triton X-100 caused their dissociation into monomers. Low pH, low ionic strength, and millimolar concentrations of calcium ions favored the maintenance of multimers. The results of this study demonstrate that the participation of tyrosinase, TRP-1, and TRP-2 in a multimeric complex could have important physiologic consequences, and raise the possibility that some of the well-known interactions between coat color genes may be explained by intermolecular interactions between the gene products.


Asunto(s)
Oxidorreductasas Intramoleculares , Glicoproteínas de Membrana , Monofenol Monooxigenasa/análisis , Oxidorreductasas , Animales , Calcio/farmacología , Centrifugación por Gradiente de Densidad , Concentración de Iones de Hidrógeno , Immunoblotting , Isomerasas/análisis , Isomerasas/química , Melanocitos/química , Melanocitos/enzimología , Melanoma Experimental , Ratones , Ratones Endogámicos C57BL , Peso Molecular , Monofenol Monooxigenasa/química , Octoxinol/farmacología , Concentración Osmolar , Proteínas/análisis , Proteínas/química , Sacarosa , Células Tumorales Cultivadas
11.
Gene ; 275(1): 103-6, 2001 Sep 05.
Artículo en Inglés | MEDLINE | ID: mdl-11574157

RESUMEN

Artificial fusion of human monocyte with Cloudman S91 mouse melanoma cells resulted in hybrids that showed increased motility in vitro, enhanced metastatic potential in vivo, and also tended to be super melanotic (Rachkovsky et al., Clin. Exp. Metastasis 16 (1998) 299). However, no gene derived from monocytes has been shown to be expressed in these hybrids until now. Similar observations have also been noted in hybrids originating from mouse macrophage and mouse melanoma cells. Having the advantage of species differences in mouse x human hybrids, we are able, this time, to show by RT-PCR that some genes specific to the human genome are expressed in these hybrids, indicating that not only is the genomic DNA from parental monocytes integrated in the hybrids but also some genes are being expressed. This observation may lead us to find contributory genes from monocyte and/or macrophage that are responsible for modulating the genotypes and hence the phenotypes in the hybrids.


Asunto(s)
Células Híbridas/metabolismo , Melanoma/genética , Monocitos/metabolismo , Animales , Proteína Activadora de G (M2) , Expresión Génica , Humanos , Melanoma/patología , Ratones , Osteonectina/genética , Proteínas/genética , ARN/genética , ARN/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Células Tumorales Cultivadas
12.
FEBS Lett ; 302(2): 126-8, 1992 May 11.
Artículo en Inglés | MEDLINE | ID: mdl-1633843

RESUMEN

Dopachrome tautomerase (DT) (EC 5.3.2.3) is a melanocyte-specific, membrane-associated, heat-labile, non-dialyzable, protease-sensitive factor which catalyzes the isomeric rearrangement of dopachrome to 5,6-dihydroxyindole-2-carboxylic acid (DHICA), apparently through a tautomerization reaction. Metal ions such as Cu, Ni, Co, Zn, Mn, Ca, Al, and Fe can also catalyze the dopachrome/DHICA isomerization. How is the reaction regulated in vivo? An attractive possibility would be that DT is a metalloenzyme. Here we present evidence that this may indeed be the case. Purified preparations of DT and tyrosinase, obtained from Cloudman S91 mouse melanoma cells, were assayed in the presence of a variety of metal chelators including EDTA (predominantly Ca and Mg), EGTA (predominantly Ca), phenylthiourea (PTU) (predominantly Cu), 2,2'-dipyridyl (predominantly Fe); 1,10-phenanthroline (predominantly Fe), and 2,3-dihydroxybenzoic acid (predominantly Fe). In addition, DT activity was assayed in the presence of two non-chelating structural analogs of 1,10-phenanthroline. Results were as follows: (i) iron chelators inhibited DT activity with no effects on tyrosinase activity; (ii) inhibition by the chelators was reversible with the addition of ferrous iron; (iii) 1,10-phenanthroline pre-complexed to ferrous iron was not inhibitory to DT; (iv) non-chelating analogs of phenanthroline were not inhibitory to DT; (v) PTU was inhibitory to tyrosinase but not DT; (vi) Ca2+ and Mg2+ chelators had little effect on either enzyme activity. Finally, studies with glycosylation inhibitors, glycosylase enzymes, and immobilized lectins, indicated that DT is a glycoprotein. The results suggest that DT is a metal-containing glycosylated enzyme, possibly with ferrous iron at its catalytic center.


Asunto(s)
Compuestos Ferrosos/metabolismo , Glicoproteínas/metabolismo , Indolquinonas , Oxidorreductasas Intramoleculares , Isomerasas/metabolismo , 2,2'-Dipiridil/farmacología , Animales , Quelantes/farmacología , Ácido Edético/farmacología , Compuestos Ferrosos/farmacología , Hidroxibenzoatos/farmacología , Indoles/metabolismo , Isomerasas/antagonistas & inhibidores , Melanoma Experimental/enzimología , Ratones , Monofenol Monooxigenasa/antagonistas & inhibidores , Monofenol Monooxigenasa/metabolismo , Fenantrolinas/farmacología , Quinonas/metabolismo , Células Tumorales Cultivadas
13.
FEBS Lett ; 276(1-2): 205-8, 1990 Dec 10.
Artículo en Inglés | MEDLINE | ID: mdl-2265702

RESUMEN

Treatment of Cloudman S91 melanoma cells with retinoic acid (RA) inhibits MSH-induced tyrosinase activity and melanin formation [(1990) J. Invest. Dermatol. 94, 461-464]. We report here, however, that in spite of inhibiting MSH-induced pigmentation, RA treatment caused a marked increase in MSH binding capacity for both cell surface and internal MSH binding sites. The stimulation was dose- and time-dependent and reversible, with half-maximal effects seen at 2 microM RA. Stimulation of MSH binding was seen as early as 3 h after exposure of cells to RA. Cell surface and internal binding activity increased in concert. Scatchard analysis indicated that increased MSH binding resulted from a 3-4-fold increase in the number of sites with no significant difference in their affinity for MSH. It appears that in suppressing MSH-induced melanogenesis, RA elicited a compensatory up-regulation of the MSH receptor system.


Asunto(s)
Hormonas Estimuladoras de los Melanocitos/metabolismo , Receptores de la Hormona Hipofisaria/metabolismo , Tretinoina/farmacología , Animales , Unión Competitiva , Línea Celular , Membrana Celular/metabolismo , Cinética , Melanoma Experimental , Ratones , Receptores de la Hormona Hipofisaria/efectos de los fármacos
14.
Clin Exp Metastasis ; 20(4): 365-73, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-12856724

RESUMEN

GnT-V generated, beta1,6-branched polylactosamines are a common feature shared by normal granulocytes, monocytes, and a variety of malignant cells. Furthermore, activation of GnT-V in oncogenic transformation induces invasiveness and metastatic potential in mice as well as in humans. In view of the common expression of lymphocytic/monocytic trait, motility, and GnT-V by metastatic cancer cells, macrophage fusion hybrids were generated in vitro with Cloudman S91 mouse melanoma cells to test whether the parental traits are co-expressed in hybrids and how those are related to altered phenotypes in relation to metastasis. In fact, the fusion hybrids are highly metastatic in vivo, motile in vitro, and express macrophage-associated traits of increased GnT-V activity, beta1,6 branching, and polylactosamine content. A Spontaneously formed lung melanoma metastases have been identified and characterized as host x tumor hybrid containing higher DNA content than parental cells and increased GnT-V activity. The results, taken together, could reflect prior fusion of tumor-associated macrophages with cells of the primary tumor, and therefore establish a possible common link between elevated expression of GnT-V and malignant transformation, a well-known report. Moreover, the fusion hybrids with metastatic potential ranging from high to low offer a genetically matched model system, for identification and characterization of differentially expressed genes in association with metastasis, since the fusion partners are derived from the same species of mouse (DBA/2J).


Asunto(s)
Macrófagos/metabolismo , N-Acetilglucosaminiltransferasas/fisiología , Metástasis de la Neoplasia/patología , Neoplasias/metabolismo , Animales , Transformación Celular Neoplásica , Humanos , Células Híbridas , Ratones
15.
Invest Ophthalmol Vis Sci ; 17(6): 511-4, 1978 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-96039

RESUMEN

Modern techniques offer an opportunity for a more complete evaluation of melanin production in the uvea and retinal pigment epithelium (RPE). By measuring the release of tritium from tritiated tyrosine in homogenized samples of adult bovine RPE as well as iris and choroid, tyrosinase activity could be demonstrated in both the uveal tract and the RPE. Phenylthiourea, a specific tyrosinase inhibitor, markedly decreased tyrosinase activity, whereas 3-iodo-tyrosine, a tyrosine hydroxylase inhibitor, had no effect. These techniques indicate tyrosinase activity in the uveal tract and the RPE of adult cattle. This is the first biochemical demonstration of tyrosinase in adult RPE.


Asunto(s)
Catecol Oxidasa/análisis , Monofenol Monooxigenasa/análisis , Epitelio Pigmentado Ocular/enzimología , Úvea/enzimología , Animales , Bovinos , Coroides/enzimología , Iris/enzimología , Melanocitos/enzimología
16.
Ann N Y Acad Sci ; 885: 100-16, 1999 Oct 20.
Artículo en Inglés | MEDLINE | ID: mdl-10816644

RESUMEN

Ultraviolet B (UVB) radiation in the skin induces pigmentation that protects cells from further UVB damage and reduces photocarcinogenesis. Although the mechanisms are not well understood, our laboratory has shown that UVB radiation causes increased MSH receptor activity by redistributing MSH receptors from internal pools to the external surface, with a resultant increase in cellular responsiveness to MSH. By this means, UVB and MSH act synergistically to increase melanin content in the skin of mice and guinea pigs. In humans, MSH causes increased skin pigmentation, predominantly in sun-exposed areas. We have shown recently that UVB irradiation and exposure to MSH or to dbcAMP, stimulates production of mRNAs for both alpha MSH receptors and POMC in human melanocytes and keratinocytes. This indicates that at least one action of UVB on the pigmentary system is mediated through increased MSH receptor production, as well as through the production of the signal peptides, MSH and ACTH, that can further activate MSH receptors. The results add support to the hypothesis that the effects of UVB on cutaneous melanogenesis are mediated through a series of coordinated events in which MSH receptors and POMC-derived peptides play a central role.


Asunto(s)
Queratinocitos/efectos de la radiación , Melaninas/biosíntesis , Melanocitos/efectos de la radiación , Proopiomelanocortina/fisiología , Receptores de la Hormona Hipofisaria/fisiología , Piel/efectos de la radiación , Rayos Ultravioleta , Animales , Regulación de la Expresión Génica/efectos de la radiación , Cobayas , Humanos , Queratinocitos/fisiología , Melanocitos/fisiología , Ratones , Proopiomelanocortina/genética , Receptores de la Hormona Hipofisaria/efectos de la radiación
17.
Melanoma Res ; 10(6): 507-14, 2000 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11198471

RESUMEN

This article reviews a long-standing hypothesis that metastases might be initiated through the generation of hybrids between primary tumour cells and tumour-infiltrating leucocytes such as macrophages. In this concept the hybrids become metastatic through expression of the leucocyte motility phenotype. A history of the hybrid hypothesis is presented along with recent evidence on how macrophage x tumour cell hybridization could account for some of the most defining characteristics of metastatic cells: aneuploidy, enhanced motility, aberrant glycosylation and, particularly seen in melanoma, phenotypic diversity.


Asunto(s)
Hibridación Genética , Macrófagos/metabolismo , Metástasis de la Neoplasia , Neoplasias/etiología , Neoplasias/patología , Aneuploidia , Animales , Apoptosis , Movimiento Celular , Regulación Neoplásica de la Expresión Génica , Glicosilación , Humanos , Células Híbridas , Macrófagos/citología , Ratones , Fenotipo
18.
Methods Mol Med ; 35: 419-36, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-21390821

RESUMEN

Gene therapy approaches to cancer treatment have been limited by the ability of the delivery vectors to achieve specific high-level expression within tumor cells or the tumor environment following systemic administration. Numerous physical barriers exist in the delivery of therapeutic agents (including drugs, viruses, and liposomes) to solid tumors that can compromise the effectiveness (1), thus stimulating the search for alternative methods of delivery. Whereas it has been known for some time that spores of anaerobic Clostridium can germinate within the necrotic spaces of human tumors, they are limited to larger hypoxic tumors and are inaccessible to smaller metastases (2,3). The ability of motile, facultatively anaerobic Salmonella to target tumors following systemic administration, preferentially amplify within them, and express effector genes such as the herpes simplex virus thymidine kinase (HSV-TK) makes them an attractive alternative to Clostridia, liposome and viral-based delivery vectors (4). These Salmonella were attenuated by poly-auxotrophic mutations, which limited their pathogenesis in normal tissues, but retained high-level replication within tumors, resulting in tumor suppression of both primary and metastatic tumors (4,5). The attenuating mutations were added stepwise following in vitro and in vivo selection and screening methods. Although live-attenuated vectors for use in humans requires defined genetic mutations, our experience has shown that combinations of point-mutations and frame-shift mutations allows for rapid isolation of strains with multiple mutations having desirable properties, which can later be defined and/ or stabilized. Bearing this in mind, we present the basic methodology for the development of tumor-targeting facultative anaerobes with effector gene delivery capabilities that we applied to Salmonella.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA